Triple-drug malaria therapy shows promise in large african trial

NCT ID NCT03923725

First seen Nov 18, 2025 · Last updated May 01, 2026 · Updated 13 times

Summary

This study tested whether using three drugs together (triple therapy) works as well as the standard two-drug treatment for uncomplicated malaria in children across Africa. Over 2,500 children aged 6 months to 12 years took part. The goal was to see if the triple combination could still cure malaria and prevent the parasite from becoming resistant to current medicines.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA (UNCOMPLICATED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah

    Conakry, B.P. 2649, Guinea

  • Centre for Malaria and Other Tropical Diseases (CEMTROD)

    Ilorin, Kwara State, 1459, Nigeria

  • College of Medicine and Health Sciences, University of Rwanda

    Kigali, Rwanda

  • Epicentre Niger

    Niamey, BP: 13 330, Niger

  • Institut des Sciences et Techniques (INSTech)

    Bobo-Dioulasso, Burkina Faso

  • Kinshasa School of Public Health

    Kinshasa, BP 11850 Kin, Democratic Republic of the Congo

  • MRC Unit The Gambia at LSHTM

    Fajara, City of Banjul, 273, The Gambia

  • National Institute For Medical Research (NIMR), Tanga Medical Research Centre

    Tanga, Tanzania

Conditions

Explore the condition pages connected to this study.